These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21446893)

  • 1. Association between echocardiographic parameters and brain natriuretic peptide levels in treated hypertensive patients.
    Masugata H; Senda S; Murao K; Okuyama H; Inukai M; Hosomi N; Iwado Y; Noma T; Kohno M; Goda F
    Clin Exp Hypertens; 2011; 33(3):187-91. PubMed ID: 21446893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
    Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T
    Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.
    Murakami Y; Shimada T; Inoue S; Shimizu H; Ohta Y; Katoh H; Nakamura K; Ishibashi Y
    Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension.
    Tsioufis C; Stougiannos P; Taxiarchou E; Skiadas I; Chatzis D; Thomopoulos C; Lalos S; Stefanadis C; Kallikazaros I
    J Hypertens; 2006 May; 24(5):965-72. PubMed ID: 16612260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
    Uusimaa P; Tokola H; Ylitalo A; Vuolteenaho O; Ruskoaho H; Risteli J; Linnaluoto M; Peuhkurinen K;
    Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM; Pinto F; Ravara L; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concentration of atrial and brain natriuretic peptide in patients with idiopathic hypertension.
    Irzmanski R; Barylski M; Banach M; Piechota M; Kowalski J; Cierniewski C; Pawlicki L
    Med Sci Monit; 2007 Oct; 13(10):CR449-56. PubMed ID: 17901852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension.
    López B; Castellano JM; González A; Barba J; Díez J
    Hypertension; 2007 Nov; 50(5):977-83. PubMed ID: 17846346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible correlation among echocardiographic measures, serum brain natriuretic peptide, and angiotensin II levels in hypertensive kidney transplanted children.
    Gheissari A; Sabri M; Pirpiran M; Merrikhi A
    Exp Clin Transplant; 2013 Apr; 11(2):128-33. PubMed ID: 23477424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients.
    Wei T; Zeng C; Chen L; Chen Q; Zhao R; Lu G; Lu C; Wang L
    Eur J Heart Fail; 2005 Jan; 7(1):75-9. PubMed ID: 15642535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left venticular hypertrophy.
    Kohno M; Minami M; Kano H; Yasunari K; Maeda K; Hanehira T; Yoshikawa J
    Metabolism; 2000 Oct; 49(10):1356-60. PubMed ID: 11079829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events.
    Suzuki M; Hamada M; Yamamoto K; Kazatani Y; Hiwada K
    Hypertens Res; 2002 Sep; 25(5):669-76. PubMed ID: 12452317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension.
    Conen D; Zeller A; Pfisterer M; Martina B
    Am J Cardiol; 2006 Jan; 97(2):249-52. PubMed ID: 16442372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension.
    Suzuki M; Yamamoto K; Watanabe S; Iwata T; Hamada M; Hiwada K
    Am J Med; 2000 Jun; 108(8):627-33. PubMed ID: 10856410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients.
    Ishigami J; Iimori S; Kuwahara M; Sasaki S; Tsukamoto Y
    Nephrology (Carlton); 2014 Dec; 19(12):777-83. PubMed ID: 25142830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doppler-derived indexes and B-type natriuretic peptide in prediction of paroxysmal atrial fibrillation in essential hypertension: a prospective study.
    Badran HM; Eid MA; Michael A
    Echocardiography; 2007 Oct; 24(9):911-22. PubMed ID: 17894569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease.
    Tripepi G; Mattace-Raso F; Mallamaci F; Benedetto FA; Witteman J; Malatino L; Zoccali C
    Hypertension; 2009 Oct; 54(4):818-24. PubMed ID: 19635983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cardio-ankle vascular index with brain natriuretic peptide levels in hypertension.
    Masugata H; Senda S; Inukai M; Murao K; Himoto T; Hosomi N; Murakami K; Noma T; Kohno M; Okada H; Goda F
    J Atheroscler Thromb; 2012; 19(3):255-62. PubMed ID: 22056595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.